NMPA Issues Interim Provisions for Overseas MAHs’ Designated Domestic Responsible Persons
The National Medical Products Administration (NMPA) has released the “Interim Provisions on the Management of...
NMPA
NMPA Draft Proposal Aims to Strengthen Supervision of Drug Entrusted Manufacturing
The National Medical Products Administration (NMPA) has released a draft proposal titled “Announcement on Strengthening...
China’s NMPA Issues Guidelines for Domestic Manufacturing of Imported Medical Devices
The National Medical Products Administration (NMPA) has released a notification aimed at further clarifying the...
NMPA Releases 84th Batch of Reference Drugs for GQCE and First Batch Stripped of Status
The National Medical Products Administration (NMPA) has released the 84th batch of reference drugs for...
China’s NMPA and Denmark’s Medicines Agency Commit to Enhanced Regulatory Cooperation
The National Medical Products Administration (NMPA) of China and the Danish Medicines Agency have signed...
China’s NMPA Launches Pilot Program for Phased Manufacturing of Biological Products
The National Medical Products Administration (NMPA) has officially released the “Pilot Work Plan for Phased...
China’s NMPA Greenlights Pilot Plan for Phased Manufacturing of Biological Products
The National Medical Products Administration (NMPA) has given its stamp of approval to the “Pilot...
NMPA Sets Forthcoming Guidelines for Domestic Drug Refiling Procedures
The National Medical Products Administration (NMPA) has issued a notification outlining the requirements for the...
China’s NMPA Proposes Rewards for Internal Whistleblowers in Drug and Medical Device Safety Reporting
The National Medical Products Administration (NMPA) of China has issued a draft proposal for the...
NMPA Expands Generic Quality Consistency Evaluation with 83rd Batch of Reference Drugs
The National Medical Products Administration (NMPA) in China has announced the release of the 83rd...
China Unveils Medical Insurance Eligibility Management System for Designated Healthcare Personnel
The National Healthcare Security Administration (NHSA), National Health Commission, and National Medical Products Administration (NMPA)...
China’s NMPA Releases Standards for Brain-Computer Interface Medical Devices
The National Medical Products Administration (NMPA) in China has issued a notification confirming the establishment...
GSK’s Blenrep-BorDex Combo Earns Breakthrough Therapy Designation in China for Multiple Myeloma
The UK-based pharmaceutical colossus, GSK (LON: GSK, NYSE: GSK), has secured a Breakthrough Therapy Designation...
CDE Launches CARE Plan to Streamline Rare Disease Drug Development
The Center for Drug Evaluation has unveiled the ‘Pilot Work Plan for Patient-Centered Action for...
South Korea’s MFDS Aims to Slash Drug Approval Times with New Innovation Plan
South Korea’s Ministry of Food and Drug Safety (MFDS) has unveiled an ambitious plan to...
China’s CDE Issues Draft Guidelines for Biosimilar Pharmaceutical Similarity Research
The Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA) has released...
China Opens Doors to Foreign Biotech and Wholly-Owned Hospitals in Healthcare Sector Expansion
China’s Ministry of Commerce, National Health Commission, and National Medical Products Administration (NMPA) have jointly...
NMPA Unveils 82nd Batch of Reference Drugs for Generic Quality Evaluation
The National Medical Products Administration (NMPA) has announced the release of the 82nd batch of...
China’s NMPA Suspends Dr. Reddy’s Atomoxetine Imports Amid Quality Concerns
BEIJING—The National Medical Products Administration (NMPA) has issued a notification to immediately suspend the import,...
NMPA Suspends Jeisys Medical Inc.’s Nd:YAG Laser Equipment Over Quality Concerns
BEIJING—The National Medical Products Administration (NMPA) of China has issued a notification to immediately suspend...